REGENXBIO Inc. — Form 8-K
Filed October 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 24/100
What the filing says
REGENXBIO Inc. filed an 8-K on October 16, 2026 reporting Item 5.02 regarding departure of directors/officers and compensatory arrangements. The filing text provided does not contain specific details about the actual compensation amounts, officer names, departure dates, or the nature of the arrangement — only that such arrangements were disclosed.
Why this rating
Standard executive compensation disclosure with no material financial figures disclosed in excerpt. Routine 8-K filing absent concrete transaction details or financial impact.
Extracted items
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.